What's your question?

Quesra Latest Questions

  1. Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.   Key Market Insights Presently, over 90 non-viral drug delivery systems developers are engaged in tRead more

    Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.

     

    Key Market Insights

    • Presently, over 90 non-viral drug delivery systems developers are engaged in the healthcare market, located across the globe
    • Currently, more than 95 non-viral drug delivery systems are offered by several players in the healthcare domain
    • The partnership activity for non-viral drug delivery systems in the healthcare domain has grown at a CAGR of over 40%, in the past three years, 2018-2021
    • The projected future opportunity for companies engaged in this field is expected to be well distributed across type of molecule, type of biologic delivered, type of technology, target therapeutic area, type of payment model and key geographical regions.

     

    Table of Contents

     

    1. PREFACE

    1.1.                  Scope of the Report

    1.2.                  Research Methodology

    1.3.                  Market Segmentations

    1.4.                  Key Questions Answered

    1.5.                  Chapter Outlines

     

    1. EXECUTIVE SUMMARY

     

    1. INTRODUCTION

    3.1.                  Chapter Overview

    3.2.                  Need for Targeted Drug Delivery

    3.3.                  Advanced Approaches for Delivery of Drug Payloads

    3.4.                  Future Perspectives

     

    1. MARKET LANDSCAPE

    4.1.                  Chapter Overview

    4.2.                  Intracellular Drug Delivery: List of Technologies

    4.3.                  Intracellular Drug Delivery: List of Technology Developers

     

    1. KEY INSIGHTS

    5.1.                  Chapter Overview

    5.2.                  Analysis by Type of Technology

    5.3.                  Analysis by Company Size and Type of Molecule Delivered

    5.4.                  Analysis by Location of Headquarters (Region-wise) and Type of Service Provider

    5.5.                  Analysis by Company Size and Location of Headquarters

     

    1. COMPANY COMPETITIVENESS ANALYSIS

    6.1.                  Chapter Overview

    6.2.                  Assumptions / Key Parameters

    6.3.                  Methodology

    6.4.                  Company Competitiveness Analysis: Benchmarking of Portfolio Strength

    6.5.                  Company Competitiveness Analysis: Benchmarking of Partnership Strength

     

    1. COMPANY PROFILES

    7.1.                  Arcturus Therapeutics

    7.2.                  Bio-Path

    7.3.                  CureVac

    7.4.                  Entos Pharmaceuticals

    7.5.                  eTheRNA immunotherapies

    7.6.                  Matinas BioPharma

    7.7.                  MDimune

    7.8.                  PCI Biotech

     

    1. PATENT ANALYSIS

    8.1.                  Chapter Overview

    8.2.                  Scope and Methodology

    8.3.                  Intracellular Drug Delivery Technologies: Patent Analysis

    8.4.                  Intracellular Drug Delivery Technologies: Patent Valuation Analysis

     

    1. PARTNERSHIPS AND COLLABORATIONS

    9.1.                  Chapter Overview

    9.2.                  Partnership Models

    9.3.                  Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations

     

    1. OPPORTUNITY ASSESSMENT FRAMEWORK: KALBACH INNOVATION MODEL, COMPETITVE ASSESSMENT FRAMEWORK AND BCG MATRIX

    10.1.                Chapter Overview

    10.2.                Kalbach Innovation Model

    10.3.                Competitive Assessment Framework

    10.4.                BCG Matrix

     

    1. MARKET FORECAST AND OPPORTUNITY ANALYSIS

    11.1.                Chapter Overview

    11.2.                Key Assumptions

    11.3.                Forecast Methodology

    11.4.                Global Non-Viral Intracellular Drug Delivery Technologies Market, 2022-2035

    11.5.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Payment Model Employed, 2022 and 2035

    11.6.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Molecule Delivered, 2022 and 2035

    11.7.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Biologic Delivered, 2022 and 2035

    11.8.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Technology, 2022 and 2035

    11.9.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Target Therapeutic Areas, 2022 and 2035

    11.10.              Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Geography, 2022 and 2035

     

    1. CONCLUDING REMARKS

     

    1. EXECUTIVE INSIGHTS

     

    1. APPENDIX 1: TABULATED DATA

     

    1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

     

    News article

    Modular Facility Manufacturers Market

     

    Learn from experts:  do you know about these emerging industry trends?

    Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

    CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

    See less
  1. Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers   Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies andRead more

    Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers

     

    Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies and Services Market, 2023-2035” report to its list of offerings.

     

    The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this market, across different geographies. Amongst other elements, the report includes:

     

    • An executive summary of the insights captured during our research. It offers a high-level view on the current state of nanoparticle formulation market, including both technologies and services, and its likely evolution in the mid to long term.
    • A general overview of the nanoparticles, highlighting the different types of nanoparticles, methods of nanoparticle formulation, challenges associated with formulation of nanoparticles and need for outsourcing such operations.
    • A detailed assessment of the current technology landscape of nanoparticle formulations technologies, based on several relevant parameters.
    • A comprehensive assessment of the overall service providers landscape of the companies offering nanoparticle formulation service, based on several relevant parameters.
    • An insightful competitiveness analysis of nanoparticle formulation technologies developed by various stakeholders based in North America, Europe, and Asia-Pacific, Middle East and North Africa and Rest of the World.
    • A detailed competitiveness analysis of nanoparticle formulation service providers.
    • Elaborate profiles of prominent players developing technologies and offering services for nanoparticle formulation across North America, Europe and Asia-Pacific.
    • A detailed analysis of the partnerships inked between stakeholders in nanoparticle formulation market, since 2018.
    • An in-depth analysis of various patents that have been filed / granted related to nanoparticle formulation, since 2018.
    • An insightful framework evaluating types of nanoparticles based on several relevant parameters.
    • A case study of the recent technology licensing agreements, along with information on deal amounts.
    • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
    • Type of Nanoparticle Formulated
    • Organic Nanoparticles
    • Inorganic Nanoparticles
    • Carbon-based Nanoparticles

     

    • Type of Organic Nanoparticle Formulated
    • Polymeric Nanoparticles
    • Lipid Nanoparticles
    • Viral Nanoparticles
    • Protein-based Nanoparticles
    • Other Organic Nanoparticles

     

    • Scale of Operation
    • Preclinical
    • Clinical
    • Commercial

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America

     

    Key companies covered in the report

    • Ascension Sciences
    • DIANT Pharma
    • ExonanoRNA
    • Nanoform
    • NanoVation Therapeutics
    • NanoVelos
    • NTT Biopharma
    • Organoid-X BioTech
    • Vaxinano

     

     

    To view more details on this report, click on the link:

    https://www.rootsanalysis.com/reports/nanoparticle-formulation-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

    Novel Cell Cytometers: Need of the Hour

     

    Learn from our recently published whitepaper: –

    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

    See less
  1. Upon realizing the potential of digital biomanufacturing over traditional processes, players are actively undertaking initiatives to adopt advanced platforms to drive operational excellence, visibility, control and synchronization in bioprocessing   Roots Analysis is pleased to announce the pubRead more

    Upon realizing the potential of digital biomanufacturing over traditional processes, players are actively undertaking initiatives to adopt advanced platforms to drive operational excellence, visibility, control and synchronization in bioprocessing

     

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Digital Biomanufacturing Market, 2023-2035.”

     

    The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:

    • An executive summary of the insights captured during our research, offering a high-level view on the current state of the digital manufacturing market and its likely evolution in the mid-long term.
    • A general introduction to digital biomanufacturing, featuring a detailed discussion on various types of technologies that support digital bioprocessing. In addition, it presents the key challenges and future perspectives associated with the employment of digital technologies in the field of biomanufacturing.
    • A detailed assessment of the overall market landscape of companies offering digital manufacturing technologies (PAT, DAS, MES and digital twins), based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company (CDMO provider and software provider), number of platforms offered, deployment options (cloud based, on-premises, corporate datacenter and hybrid), platform capabilities (process automation, bioprocess optimization and controls, process connectivity, scalability, data integration, process monitoring and visualization, performance analysis, report generation and documentation, smart manufacturing, document control, production tracking, performance analysis and data integration), software capabilities (process intelligence, data integration, real-time process monitoring, data visualization, performance analysis and control prediction, reporting and data management), type(s) of biologic(s) manufactured, other compatible platforms (artificial intelligence / machine learning / cloud based, big data, internet of things, augmented reality and virtual reality) and type of end user(s) (industry and non-industry), integrating software (enterprise resource planning (ERP), manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered (training, implementation / upgradation and general support), area(s) of application (asset / process management, clinical trials, personalized treatment, medical training, surgical planning, health monitoring and diagnosis).
    • A detailed competitiveness analysis of digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on supplier strength (in terms of years of experience and company size), technology portfolio (considering deployment options, number of platform capabilities, type of end user(s), software capabilities, area(s) of application, type(s) of twin(s)) and type(s) of biologic(s) manufactured.
    • Elaborate profiles of key players (companies offering more than one platform and established before 2012) engaged in the digital biomanufacturing domain, which are actively providing software based on PAT, DAS, MES and digital twins. Each profile includes a brief overview of the company, along with information on capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.
    • A benchmark analysis highlighting the capabilities of companies (in terms of their expertise across various platforms related to the manufacturing of biologics) engaged in this domain, across key peer groups.
    • An analysis featuring information on recent partnerships inked between stakeholders engaged in this domain, based on several relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity, during the period 2018-2022.
    • A detailed analysis highlighting the market concentration of key industry stakeholders (companies offering more than one platform) across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.
    • A detailed industry lifecycle analysis that indicates various stages, including emergence, growth, maturation and eventual decline for the digital biomanufacturing industry. The primary purpose of this analysis is to develop a better understanding of the current position / phase of the industry on the lifecycle chart (based on historical trends, partnership activity and various investments made by players engaged in this domain) and predict the upcoming events that are likely to drive the growth of this domain. Further, it presents short-term and long-term impacts of various key parameters that are expected to highly impact the wider adoption of digitalization in the field of biomanufacturing.
    • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
    • Type of Technology
    • Process Analytical Technology (PAT)
    • Data Analysis Software (DAS)
    • Manufacturing Execution Systems (MES)
    • Digital Twins

     

    • Deployment Options
    • Cloud-based Deployment Options
    • On-premises Deployment Options

     

    • Type(s) of Biologic(s) Manufactured
    • Antibodies
    • Cell and Gene Therapies
    • Proteins
    • Vaccines
    • Others

     

    • Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North America

     

    Key companies / organizations covered in the report

    • AspenTech
    • net
    • Dassault Systèmes
    • FUJIFILM Diosynth Biotechnologies
    • GE Healthcare
    • Körber
    • Merck
    • Sartorius
    • Thermo Fisher Scientific

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    TCR Therapies: An Emerging Therapeutic Modality

    Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. The growing demand for buffers and challenges associated with buffer manufacturing has prompted various pharmaceutical companies to leverage the expertise of players offering novel buffer manufacturing systems and related services.   Roots Analysis has announced the addition of “Buffer PreparatRead more

    The growing demand for buffers and challenges associated with buffer manufacturing has prompted various pharmaceutical companies to leverage the expertise of players offering novel buffer manufacturing systems and related services.

     

    Roots Analysis has announced the addition of “Buffer Preparation Market: Focus on Buffer Manufacturing Systems and Service Providers, 2023-2035” report to its list of offerings.

    The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elem        ents, the report includes:

    • An executive summary of the insights captured during our research, offering a high-level view on the current state of the buffer preparation systems market and its likely evolution in the mid-to-long term.
    • A general overview of buffer manufacturing, along with information on conventional and novel methods of buffer manufacturing. In addition, the chapter highlights the challenges associated with buffer manufacturing, advantages of outsourcing buffer manufacturing and key considerations while selecting an outsourcing partner. Further, it concludes with a discussion on future perspectives in this market.
    • A detailed assessment of the overall market landscape of buffer preparation / manufacturing systems, based on several relevant parameters.
    • A comprehensive product competitiveness analysis of buffer manufacturing systems, based on developer power and product competitiveness.
    • Elaborate profiles of key players (shortlisted based on proprietary criterion) engaged in the development of buffer preparation system, including a brief overview of the company, details related to product portfolio, recent developments and an informed future outlook.
    • A detailed assessment of the overall market landscape of buffer manufacturing service providers, based on several relevant parameters.
    • A comprehensive company competitiveness analysis of buffer manufacturing service providers based in North America, Europe and Asia, based on supplier power and company competitiveness.
    • Elaborate profiles of key companies (shortlisted based on proprietary criterion) providing buffer manufacturing services including a brief overview of the company, key executives, company portfolio, recent developments and an informed future outlook.
    • A detailed analysis of partnerships inked between stakeholders engaged in this industry, since 2017, based on several relevant parameters.
    • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
    • Scale of Operation
    • Preclinical / Clinical
    • Commercial
    • Type of System Component
    • Single-use Buffer Mixing / Preparation Equipment
    • Reusable Buffer Mixing / Preparation Equipment
    • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

     

    Key companies covered in the report

    • Asahi Kasei
    • Avantor
    • Canvax
    • Cytiva
    • Lonza
    • Merck
    • Pall Corporation
    • Thermo Fisher Scientific

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/buffer-preparation-market.html

     

    News article

    Exosome Therapeutics Market

     

    Learn from our recently published whitepaper: –

    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

     

     

    See less